# Validation Report: tersigni-et-al-2024-syncytiotrophoblast-extracellular-vesicles-previa-pas.md

**Validated against**: `43032_2024_Article_1491.pdf` (Tersigni, Di Simone et al. 2024) — sources only, for all five categories (no baseline document used this session, per explicit instruction).

**Methodology**: `VALIDATION.md` rubric — 5 categories (Accuracy, Relevance, Clarity, Completeness, Falsity) × 4 prompting styles (Contextual, Non-contextual, Argumentative, Querying) = 20 cells per response. Each cell scored 1–3; category verdict = PASS if the 4 cells sum to ≥8. Every pass is blind — derived independently, with no cross-referencing of other cells, categories, responses, or documents.

**Page split into four responses** (all comfortably under the ~150-word cap):
- **Response A** — Overview/Study design (cohort structure, PAS-within-previa framing, controls definition)
- **Response B** — Findings table (EV protein content + PLAP⁺ levels, all three comparisons)
- **Response C** — Technology + Experimental design (isolation/detection methods, n=35/35 with 6 PAS)
- **Response D** — Key conclusions (candidate-biomarker claim, underpowered caveat, cross-reference)

Validated 2026-07-30 to 2026-07-31.

---

## Response A

> "Prospective cohort study, explicitly framed by the authors as a "pilot study," single center (Fondazione Policlinico A. Gemelli IRCCS, Rome), January–June 2023. Placenta previa (PP) is the primary recruited group (all ultrasound-diagnosed, per ISUOG guidelines), with a PAS sub-analysis nested within it — 6 of 35 PP cases had pathologically confirmed PAS. This is not a PAS-specific cohort; PAS is a subgroup comparison within previa, a different pattern from most other sources in this wiki.
>
> PAS diagnosis/grade was confirmed by pathological assessment of the whole paraffin-embedded placenta per FIGO — histopathology is the PAS-confirmation method here, not imaging. Controls: uncomplicated pregnancies from routine outpatient checkups, gestational-age-matched, excluding maternal infection, autoimmune disease, multiples, preeclampsia, IUGR, and diabetes."

### Accuracy — 8/12 PASS

| Style          | Prompt                                                                                  | Finding                                                                                                                                                                                                                                                    | Score |
| -------------- | --------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----- |
| Contextual     | Act as a fact-checker and determine the accuracy of tersigni-…-pas.md.                  | Six of seven claims verified exact/verbatim; one genuine inaccuracy — the control exclusion-criteria list drops "congenital fetal abnormalities" from the source's seven-item list while presenting six as complete.                                       | 2     |
| Non-contextual | Accuracy: tersigni-…-pas.md?                                                            | Terminology-substitution audit confirms the exclusion-list gap independently via term-by-term matching, plus a minor secondary imprecision (diabetes type unspecified).                                                                                    | 2     |
| Argumentative  | Expose all errors that negatively affect the accuracy score tersigni-…-pas.md.          | An unverifiable cross-wiki comparison clause is embedded in an otherwise source-checkable paragraph; the exclusion-list gap is low-materiality on scrutiny; "diagnosis/grade" implies grade-level findings the source's own Results never actually report. | 2     |
| Querying       | Are there misinterpreted or misrepresented facts or data included in tersigni-…-pas.md? | Attribution audit: every claim traces to its correct source section except the exclusion-criteria list, which under-represents the source's actual seven-item list as six.                                                                                 | 2     |

**Sum = 8 → PASS**

### Relevance — 8/12 PASS

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as a researcher and determine the relevance of tersigni-…-pas.md. | Four of five components are relevant/necessary; "a different pattern from most other sources in this wiki" is pure meta-commentary, and the six-item exclusion list is more granular than its purpose requires. | 2 |
| Non-contextual | Relevance: tersigni-…-pas.md? | Counterfactual-removal test: five of eight discrete sub-components are necessary; three (site/date specifics, cross-wiki comparison clause, itemized exclusion list) are removable without loss. | 2 |
| Argumentative | Expose all discrepancies that negatively affect the score for tersigni-…-pas.md. | "Wrong home" test: the PP-diagnosis and PAS-diagnosis methodology sentences could each belong to their respective overview pages, but a self-contained-context justification meaningfully offsets the case. | 2 |
| Querying | Is there scope-related creep noticeable in statements included in tersigni-…-pas.md? | Specificity-gradient audit: one clause ("a different pattern from most other sources in this wiki") scores zero relevance; the rest of the lower-specificity content is necessary-but-generic reference-standard scaffolding, not true creep. | 2 |

**Sum = 8 → PASS**

### Clarity — 4/12 FAIL

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as an editor and determine the clarity of tersigni-…-pas.md. | Two verb-less sentence fragments (the opening design-descriptor list and the "Controls:" list); "primary recruited group" lacks an established contrast; "a different pattern from most other sources in this wiki" requires unstated external context; "IUGR" is never expanded. | 1 |
| Non-contextual | Clarity: tersigni-…-pas.md? | Read-aloud test: both list-style sentences read as monotone recitations rather than spoken sentences; "ISUOG" and "FIGO" have no established pronunciation; the em-dash bridge to "6 of 35" requires an unsignaled logical leap. | 1 |
| Argumentative | Expose all unclearness that negatively affects the score for tersigni-…-pas.md. | Naive-reader belief-tracking: the PP cohort's total size (35) is never stated directly, only implied via a fraction; "a different pattern from most other sources in this wiki" is an unresolvable reference; offset by one genuine positive — "not imaging" proactively heads off a likely misreading. | 1 |
| Querying | Are there ambiguous, un-concise, or confusing statements in tersigni-…-pas.md? | Conciseness/redundancy audit: "nested within it" risks conflation with a formal technical term; "explicitly framed... as" is redundant; the em-dash sentence could be tightened into one clause; sentences 2–3 create a sense of redundant restatement. | 1 |

**Sum = 4 → FAIL**

### Completeness — 4/12 FAIL

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as a cross-checker and verify that tersigni-…-pas.md is complete. | Missing the core clinical-gap rationale (no PAS biomarkers currently exist), the 11%-incidence epidemiological justification for recruiting PP patients, the ultrasound operator-dependency rationale, the STBEV gestational-age mechanism explaining why matching matters. | 1 |
| Non-contextual | Completeness: tersigni-…-pas.md? | Reader-question test: missing why PP was chosen as the recruitment target, why gestational-age matching matters mechanistically, the study's "first-time" novelty claim, and the clinical stakes motivating the search for a PAS biomarker. | 1 |
| Argumentative | Act as a critic and expose all instances of missing information that weaken tersigni-…-pas.md using the comparison material. | Materiality-weighted argument: the missing STBEV gestational-age mechanism is the standout gap — both consequential and squarely within this response's own scope, unlike the clinical-motivation and novelty claims, which more plausibly belong to a different response on this page. | 1 |
| Querying | How incomplete is tersigni-…-pas.md compared to its comparison material? | Quantitative coverage count: 9 of 18 enumerated facts present (exactly 50%). | 1 |

**Sum = 4 → FAIL**

### Falsity — 12/12 PASS (perfect)

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Using the comparison material, critically evaluate and measure how many hallucinations and false statements are present in tersigni-…-pas.md. | Detective investigation: every discrete claim traces exactly to the source; the incomplete exclusion list omits an item without claiming exhaustiveness (an accuracy matter, not a fabrication). | 3 |
| Non-contextual | Find the explain the falsity score of tersigni-…-pas.md. | Cross-location triangulation: the 6/35 PAS figure is independently corroborated across three separate locations (Results, Table 1, Figure 1 caption). | 3 |
| Argumentative | Act as a critic and expose all hallucinated false information that weaken tersigni-…-pas.md using the source material. | Adversarial steelman tested four candidates ("prospective," "nested," the incomplete exclusion list, and the 6/35 figure's attribution) — all four collapse under direct testing. | 3 |
| Querying | How false is tersigni-…-pas.md compared to its comparison material? | Necessary-condition falsification test applied to all ten discrete claims: no falsifying condition holds for any of them. | 3 |

**Sum = 12 → PASS (perfect)**

**Central defect**: the six-item control exclusion-criteria list silently drops one of the source's seven stated criteria ("congenital fetal abnormalities") while presenting the list as complete — confirmed low-materiality, but the sole recurring finding across every Accuracy method. Clarity and Completeness both fail decisively: two grammatical fragments plus an unresolvable cross-wiki reference cost Clarity, while the study's clinical rationale, epidemiological justification, and mechanistic background are almost entirely absent, driving Completeness to exactly the 50% threshold.

---

## Response B

> "| Measure | Previa (PP) vs. control | Previa+PAS vs. control | Previa+PAS vs. previa-without-PAS |
> |---|---|---|---|
> | Total EV protein content (Bradford assay) | Significantly higher, p<0.05 | Trended higher | Not statistically significant |
> | PLAP⁺ EV levels (% of total events, flow cytometry) | Significantly higher, p<0.001 | Even more significant, p<0.001 | Trended higher, not statistically significant |"

### Accuracy — 4/12 FAIL

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as a fact-checker and determine the accuracy of tersigni-…-pas.md. | Row 2 (PLAP⁺ flow cytometry) is entirely accurate. Row 1 (Bradford protein content) contains a confirmed error: "Previa+PAS vs. control: Trended higher" contradicts Figure 1d's caption, which states this comparison *was* statistically significant — the actual non-significant comparison is PAS vs. PP-without-PAS, correctly placed in the third column instead. | 1 |
| Non-contextual | Accuracy: tersigni-…-pas.md? | Internal-consistency check: Row 1's stated pattern (PP significant, but PAS-subset only "trending" vs. control) is biologically implausible against Row 2's own escalating pattern in the same table. | 1 |
| Argumentative | Expose all errors that negatively affect the accuracy score tersigni-…-pas.md. | All row labels and individual p-values check out precisely elsewhere. The table's structure compounds the Row 1 error: juxtaposed against Row 2's correctly-escalating pattern, it falsely implies the two assays disagree about PAS-vs-control significance. | 1 |
| Querying | Are there misinterpreted or misrepresented facts or data included in tersigni-…-pas.md? | Attribution audit: Row 1's Column 2 value appears to be a cross-column transposition — the genuinely non-significant Column 3 finding seems to have been mistakenly duplicated into Column 2, which should instead read "significantly higher." | 1 |

**Sum = 4 → FAIL**

### Relevance — 12/12 PASS (perfect)

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as a researcher and determine the relevance of tersigni-…-pas.md. | All table content is direct biomarker-performance data with no digression; the three-comparison structure (including PAS vs. PP-without-PAS, the clinically hardest differential) is deliberately and appropriately chosen. | 3 |
| Non-contextual | Relevance: tersigni-…-pas.md? | Counterfactual-removal test: both rows and, especially, the PAS-vs-PP-without-PAS column all pass as necessary. | 3 |
| Argumentative | Expose all discrepancies that negatively affect the score for tersigni-…-pas.md. | "Wrong home" test finds no candidate content better suited elsewhere; the one plausible discrepancy (relative-% unit choice for PLAP⁺ data) doesn't survive scrutiny, since it faithfully reflects the source's own reporting convention. | 3 |
| Querying | Is there scope-related creep noticeable in statements included in tersigni-…-pas.md? | Specificity-gradient audit: every cell and header scores maximally specific to STBEV biomarker findings; no scope creep found anywhere in this table-only response. | 3 |

**Sum = 12 → PASS (perfect)**

### Clarity — 6/12 FAIL

| Style          | Prompt                                                                          | Finding                                                                                                                                                                                                                                                                                                                                 | Score |
| -------------- | ------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----- |
| Contextual     | Act as an editor and determine the clarity of tersigni-…-pas.md.                | "Previa+PAS" notation is ambiguous between a "combined/union" and "subgroup" reading; "Trended higher" (Row 1, Col 2) inconsistently omits the "not statistically significant" qualifier used elsewhere; "even more significant, p<0.001" makes a comparative claim the table's own identical p-value notation doesn't visibly support. | 2     |
| Non-contextual | Clarity: tersigni-…-pas.md?                                                     | Read-aloud test: "PLAP⁺" requires an unstated symbol-to-speech convention; the zero-string in "p<0.001" risks being misheard; the two differently-qualified "trended higher" cells risk conflation by ear.                                                                                                                              | 2     |
| Argumentative  | Expose all unclearness that negatively affects the score for tersigni-…-pas.md. | Naive-reader belief-tracking: Row 1's wording ("trended higher") suggests weakening confidence as PAS is added, while Row 2's wording ("even more significant") suggests strengthening confidence for the same comparison type — an unresolved, table-wide belief conflict never reconciled.                                            | 1     |
| Querying       | Are there ambiguous, un-concise, or confusing statements in tersigni-…-pas.md?  | Conciseness/redundancy audit: "trended higher" conflates direction with magnitude; "even more significant" paired with identical p-value notation is unexplained; the table gives no guidance for weighting the two rows against each other.                                                                                            | 1     |

**Sum = 6 → FAIL**

### Completeness — 8/12 PASS

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as a cross-checker and verify that tersigni-…-pas.md is complete. | Core comparison results (all six cells) are present. Missing: the Western blot/immunoblot confirmation of EV identity, and the subgroup sample sizes (n=29/6/35) underlying each comparison. | 2 |
| Non-contextual | Completeness: tersigni-…-pas.md? | Reader-question test: missing the source's own explicit caveat that the null findings are likely due to underpowering (small PAS n=6), the EV-identity validation, and the proposed biological mechanism. | 2 |
| Argumentative | Act as a critic and expose all instances of missing information that weaken tersigni-…-pas.md using the comparison material. | Materiality-weighted argument: the missing underpowering caveat is the standout, well-evidenced, in-scope omission; the EV-identity confirmation is defensible as routine QC, the mechanistic explanation more properly belongs to a different response. | 2 |
| Querying | How incomplete is tersigni-…-pas.md compared to its comparison material? | Quantitative coverage count: 6 of 11 enumerated facts present (~55%). | 2 |

**Sum = 8 → PASS**

### Falsity — 8/12 PASS

| Style          | Prompt                                                                                                                                        | Finding                                                                                                                                                                                                                                                  | Score |
| -------------- | --------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----- |
| Contextual     | Using the comparison material, critically evaluate and measure how many hallucinations and false statements are present in tersigni-…-pas.md. | Detective investigation: Row 1, Col 2 ("Trended higher" for PAS vs. control) directly contradicts Figure 1d's caption, which states this comparison reached statistical significance. All other five cells match the source exactly.                     | 2     |
| Non-contextual | Find the explain the falsity score of tersigni-…-pas.md.                                                                                      | Cross-location triangulation: the Row 1/Col 2 contradiction is corroborated across two independent locations (Figure 1d caption and the main Results text).                                                                                              | 2     |
| Argumentative  | Act as a critic and expose all hallucinated false information that weaken tersigni-…-pas.md using the source material.                        | Adversarial steelman tested three additional cells for hidden hallucinations — none found — and tested whether the confirmed error could be charitably read as understatement; the source's own term-of-art usage confirms it's a genuine contradiction. | 2     |
| Querying       | How false is tersigni-…-pas.md compared to its comparison material?                                                                           | Necessary-condition falsification test applied to all six cells: exactly one fails (Row 1, Col 2).                                                                                                                                                       | 2     |

**Sum = 8 → PASS**

**Central defect**: Row 1's middle column ("Previa+PAS vs. control: Trended higher") is the single most consequential defect found anywhere on this page — a confirmed, source-contradicted swap of which comparison reached significance, likely a cross-column transposition from the correctly-stated Column 3 value. This single error costs Accuracy its only FAIL among Response B's otherwise-strong categories, and is the only confirmed hallucination in Response B's Falsity work. Relevance is flawless (perfect 12/12) — this table-only response has no digressive content whatsoever.

---

## Response C

> "Maternal peripheral venous blood (3 mL) → plasma (centrifuged 1200g) → ultracentrifuged (120,000g) EV pellet. Western blot (anti-PLAP NDOG2 antibody + anti-CD63) confirmed EV identity; Bradford assay quantified total protein; multi-color flow cytometry (CytoFLEX S) with anti-PLAP-PE antibody quantified STBEVs. These are three parallel readouts on the same specimens from one cohort, not a sequential discovery→validation design.
>
> Placenta previa n=35 (6 with confirmed PAS, 29 without) vs. controls n=35, gestational-age-matched (28–37 weeks at sampling)."

### Accuracy — 8/12 PASS

| Style          | Prompt                                                                                  | Finding                                                                                                                                                                                                                                                                                                   | Score |
| -------------- | --------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----- |
| Contextual     | Act as a fact-checker and determine the accuracy of tersigni-…-pas.md.                  | Confirmed inaccuracy: "three parallel readouts on the same specimens" is contradicted by Figure 1a's caption, which specifies the Western blot used a smaller representative subset (CTR n=6, PP n=6), not the full n=35/35 cohort used for Bradford and flow cytometry. All other claims verified exact. | 2     |
| Non-contextual | Accuracy: tersigni-…-pas.md?                                                            | Terminology-substitution audit confirms all antibody/equipment names exact; "parallel" as a description is undermined by the Western blot's differing subset size.                                                                                                                                        | 2     |
| Argumentative  | Expose all errors that negatively affect the accuracy score tersigni-…-pas.md.          | Materiality test: the subset-size discrepancy is real but low-materiality — Western blot serves a qualitative identity-confirmation role (where a representative subset is standard practice), not the quantitative comparisons that depend on the full cohort.                                           | 2     |
| Querying       | Are there misinterpreted or misrepresented facts or data included in tersigni-…-pas.md? | Attribution audit: "same specimens" is incorrectly scoped — it should note the Western blot validation step used a smaller subset, distinct from the full-cohort quantitative assays.                                                                                                                     | 2     |

**Sum = 8 → PASS**

### Relevance — 12/12 PASS (perfect)

| Style          | Prompt                                                                               | Finding                                                                                                                                                                                                   | Score |
| -------------- | ------------------------------------------------------------------------------------ | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----- |
| Contextual     | Act as a researcher and determine the relevance of tersigni-…-pas.md.                | All four components (sample-collection pipeline, measurement technologies, evidentiary-design characterization, population structure) directly serve the biomarker-utility mission — no digression found. | 3     |
| Non-contextual | Relevance: tersigni-…-pas.md?                                                        | Counterfactual-removal test: every component passes as necessary — the discovery-vs-validation-design note is particularly load-bearing for calibrating confidence in the findings.                       | 3     |
| Argumentative  | Expose all discrepancies that negatively affect the score for tersigni-…-pas.md.     | "Wrong home" test: the study-specific antibody/equipment names are appropriately homed on this paper-specific page; no candidate content better suited elsewhere.                                         | 3     |
| Querying       | Is there scope-related creep noticeable in statements included in tersigni-…-pas.md? | Specificity-gradient audit: every component scores high-to-very-high specificity to this study's own methodology; no scope creep found.                                                                   | 3     |

**Sum = 12 → PASS (perfect)**

### Clarity — 5/12 FAIL

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as an editor and determine the clarity of tersigni-…-pas.md. | Two arrow symbols ("→") used as unexplained shorthand (blood→plasma→pellet; discovery→validation); the final sentence is a verb-less fragment; dense jargon (NDOG2, CytoFLEX S) is unglossed. | 1 |
| Non-contextual | Clarity: tersigni-…-pas.md? | Read-aloud test: both arrow symbols have no standard spoken equivalent — a hard read-aloud failure; "NDOG2" has no obvious pronunciation. | 1 |
| Argumentative | Expose all unclearness that negatively affects the score for tersigni-…-pas.md. | Naive-reader belief-tracking: a reader unfamiliar with "discovery→validation design" as a concept can parse the sentence grammatically but may not grasp why its absence matters evidentially. | 2 |
| Querying | Are there ambiguous, un-concise, or confusing statements in tersigni-…-pas.md? | "Gestational-age-matched (28–37 weeks at sampling)" is ambiguously scoped — the parenthetical could be read as applying only to controls (the group it immediately follows) rather than both groups. | 1 |

**Sum = 5 → FAIL**

### Completeness — 4/12 FAIL

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as a cross-checker and verify that tersigni-…-pas.md is complete. | Missing: the intermediate 3000g spin and double-ultracentrifugation detail, NP40 lysis step, full Western blot protocol, flow cytometry calibration (Megamix beads), negative control (colorectal cancer EVs), and the statistical test used (Mann-Whitney U). | 1 |
| Non-contextual | Completeness: tersigni-…-pas.md? | Reader-question test: missing how intact vesicles were distinguished from debris (CellTrace Calcein Violet), how the cytometer was calibrated, and what statistical test determined significance. | 1 |
| Argumentative | Act as a critic and expose all instances of missing information that weaken tersigni-…-pas.md using the comparison material. | Materiality-weighted argument: the missing Western-blot-subset-size fact (n=6/6) is the standout omission — disclosing it would have prevented the "same specimens" overstatement identified under Accuracy. | 1 |
| Querying | How incomplete is tersigni-…-pas.md compared to its comparison material? | Quantitative coverage count: approximately 7 of 14 enumerated facts present (~50%). | 1 |

**Sum = 4 → FAIL**

### Falsity — 8/12 PASS

| Style          | Prompt                                                                                                                                        | Finding                                                                                                                                                                                              | Score |
| -------------- | --------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----- |
| Contextual     | Using the comparison material, critically evaluate and measure how many hallucinations and false statements are present in tersigni-…-pas.md. | Detective investigation: "same specimens" is directly contradicted by Figure 1a's caption (Western blot used n=6/6, not the full n=35/35). All other claims verified exact.                          | 2     |
| Non-contextual | Find the explain the falsity score of tersigni-…-pas.md.                                                                                      | Cross-location triangulation: only the Figure 1a caption specifies the Western blot's actual n; this one location directly contradicts "same specimens."                                             | 2     |
| Argumentative  | Act as a critic and expose all hallucinated false information that weaken tersigni-…-pas.md using the source material.                        | Adversarial steelman tested for additional hallucinations in the design-characterization and population claims — none found; the subset-size contradiction remains the sole confirmed hallucination. | 2     |
| Querying       | How false is tersigni-…-pas.md compared to its comparison material?                                                                           | Necessary-condition falsification test applied to all claims: only "same specimens" fails.                                                                                                           | 2     |

**Sum = 8 → PASS**

**Central defect**: "three parallel readouts on the same specimens" overstates the Western blot's role — it used a smaller representative subset (n=6/6) rather than the full cohort (n=35/35) used for the quantitative Bradford and flow-cytometry assays. This is the sole confirmed issue across both Accuracy and Falsity, consistently low-to-moderate in materiality since the Western blot's role was qualitative validation, not quantitative comparison. Relevance is again flawless — this is a purely methodological response with no digression.

---

## Response D

> "STBEVs are elevated in placenta previa generally and trend even higher with PAS, supporting STBEVs as a candidate liquid-biopsy biomarker to integrate with ultrasound; the study is underpowered (only 6 confirmed PAS cases) to confirm the previa-vs-PAS distinction statistically. This introduces extracellular vesicles as a biosample/biomarker category to this wiki — see [[pas-extracellular-vesicles]] for how this relates to the whole-cell circulating-trophoblast approach described elsewhere in this corpus."

### Accuracy — 8/12 PASS

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as a fact-checker and determine the accuracy of tersigni-…-pas.md. | The elevated/trend findings and the liquid-biopsy/ultrasound-integration claim are verbatim-close matches. One genuine precision issue: "underpowered (only 6 confirmed PAS cases)" attributes the limitation solely to PAS incidence, while the source's Discussion cites this jointly with "the small cohort of PP women analysed (35 cases)" as a co-equal factor. | 2 |
| Non-contextual | Accuracy: tersigni-…-pas.md? | Terminology-substitution audit confirms "liquid biopsy," "candidate biomarker," and "integrate with ultrasound" as exact source terms; the single-factor underpowering attribution is reconfirmed via term-matching. | 2 |
| Argumentative | Expose all errors that negatively affect the accuracy score tersigni-…-pas.md. | Materiality test: the omitted co-factor (small overall cohort) has low-to-moderate materiality — the core conclusion (underpowered, can't confirm the distinction) survives regardless of which contributing cause is emphasized. | 2 |
| Querying | Are there misinterpreted or misrepresented facts or data included in tersigni-…-pas.md? | Attribution audit: the underpowering explanation is only partially attributed to the Discussion's stated rationale — one of two co-cited causes is represented. | 2 |

**Sum = 8 → PASS**

### Relevance — 8/12 PASS

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as a researcher and determine the relevance of tersigni-…-pas.md. | Three of five components are squarely relevant; "introduces... as a biosample/biomarker category to this wiki" is pure wiki-taxonomy meta-commentary; the cross-reference has some genuine scientific relevance despite its navigational format. | 2 |
| Non-contextual | Relevance: tersigni-…-pas.md? | Counterfactual-removal test: the wiki-category-introduction clause is cleanly removable with no loss; the cross-reference carries some loss but is not strictly necessary. | 2 |
| Argumentative | Expose all discrepancies that negatively affect the score for tersigni-…-pas.md. | "Wrong home" test: "introduces EVs as a biosample/biomarker category to this wiki" is purely about the wiki's own category structure, which more naturally belongs on the `[[pas-extracellular-vesicles]]` topic page. | 2 |
| Querying | Is there scope-related creep noticeable in statements included in tersigni-…-pas.md? | Specificity-gradient audit: "introduces... to this wiki" scores essentially zero specificity to STBEV/PAS biology; everything else scores moderate-to-high. | 2 |

**Sum = 8 → PASS**

### Clarity — 5/12 FAIL

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as an editor and determine the clarity of tersigni-…-pas.md. | The opening sentence overloads three sub-claims plus a semicolon-joined underpowering caveat into one clause; "STBEVs" is never expanded; the pronoun "this" is used twice in quick succession with different plausible referents each time. | 1 |
| Non-contextual | Clarity: tersigni-…-pas.md? | Read-aloud test: "STBEVs" has no established pronunciation; the double-bracket wiki-link syntax has no natural spoken equivalent at all — a hard read-aloud failure. | 1 |
| Argumentative | Expose all unclearness that negatively affects the score for tersigni-…-pas.md. | Naive-reader belief-tracking: "underpowered to confirm the... distinction" risks being misread as "no distinction exists" rather than "a possibly-real distinction couldn't be statistically confirmed." | 1 |
| Querying | Are there ambiguous, un-concise, or confusing statements in tersigni-…-pas.md? | "Trend even higher" carries the same direction-vs-confidence ambiguity found elsewhere on this page, though largely mitigated by the immediately-following underpowering clause. | 2 |

**Sum = 5 → FAIL**

### Completeness — 4/12 FAIL

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Act as a cross-checker and verify that tersigni-…-pas.md is complete. | Missing: the source's "for the first time" novelty claim, the proposed biological mechanism, the call for "larger multicentre studies," the comparison to prior/competing literature, the "non-invasive/easy to access" clinical-advantage framing, and the suggested future direction of analyzing STBEV cargo. | 1 |
| Non-contextual | Completeness: tersigni-…-pas.md? | Reader-question test: missing whether this is the first study of its kind, what biologically drives the PAS-related increase, and what specific follow-up research is recommended. | 1 |
| Argumentative | Act as a critic and expose all instances of missing information that weaken tersigni-…-pas.md using the comparison material. | Materiality-weighted argument: the missing novelty claim is the standout, properly-scoped omission — it directly bears on how much corroborating evidence exists for this finding. | 1 |
| Querying | How incomplete is tersigni-…-pas.md compared to its comparison material? | Quantitative coverage count: approximately 3 of 9 enumerated facts present (~33%). | 1 |

**Sum = 4 → FAIL**

### Falsity — 12/12 PASS (perfect)

| Style | Prompt | Finding | Score |
|---|---|---|---|
| Contextual | Using the comparison material, critically evaluate and measure how many hallucinations and false statements are present in tersigni-…-pas.md. | Detective investigation: every checkable claim traces exactly to the source; the underpowering explanation is incomplete but not contradicted, since the source's two cited causes are joined by "and" — citing one doesn't negate the other. | 3 |
| Non-contextual | Find the explain the falsity score of tersigni-…-pas.md. | Cross-location triangulation: "trend to a higher concentration" and the liquid-biopsy framing are each corroborated across two independent source locations; no contradictions found anywhere. | 3 |
| Argumentative | Act as a critic and expose all hallucinated false information that weaken tersigni-…-pas.md using the source material. | Adversarial steelman tested whether citing only one of two jointly-stated causes implies the other is false — it doesn't; an incomplete account isn't a contradiction. | 3 |
| Querying | How false is tersigni-…-pas.md compared to its comparison material? | Necessary-condition falsification test applied to all claims: none fail; the n=6 figure genuinely is one of the source's stated causes. | 3 |

**Sum = 12 → PASS (perfect)**

**Central defect**: "introduces extracellular vesicles as a biosample/biomarker category to this wiki" is the standout relevance concern — pure wiki-taxonomy meta-commentary with zero connection to STBEV/PAS biology, and arguably belongs on the `[[pas-extracellular-vesicles]]` topic page rather than this paper-specific response. On Accuracy, the underpowering explanation is real but incomplete (omitting a co-stated cause) rather than false, consistent with this page's overall pattern of imprecision rather than fabrication.

---

## Cross-response comparison

| Category | A | B | C | D |
|---|---|---|---|---|
| Accuracy | 8 PASS | **4 FAIL** | 8 PASS | 8 PASS |
| Relevance | 8 PASS | **12 PASS** | **12 PASS** | 8 PASS |
| Clarity | **4 FAIL** | 6 FAIL | 5 FAIL | 5 FAIL |
| Completeness | **4 FAIL** | 8 PASS | **4 FAIL** | **4 FAIL** |
| Falsity | **12 PASS** | 8 PASS | 8 PASS | **12 PASS** |
**Verdicts**: A: PASS; B: FAIL; C: PASS; D: PASS

**Patterns across the page:**
- **Clarity fails every single time** (4/4 responses), continuing the pattern seen throughout this wiki: dense compressions of clinical/technical findings into tight word budgets consistently produce grammatical fragments, unglossed jargon/acronyms, or unpronounceable notation (arrow symbols, double-bracket wiki-links) — each response has at least one genuinely severe structural issue.
- **Completeness fails in three of four responses** (all except B), with the standout theme being that motivational/mechanistic context — why the study was designed this way, what biologically explains the findings, how confident to be in null results — is consistently the first thing cut. Response B is the exception, landing just above the PASS threshold (~55%) since a data table has less room to omit interpretive framing than prose does.
- **Response B is the only Accuracy failure on this page**, and it's a single, specific, high-confidence error: a cross-column transposition that swapped a "significant" finding for a "trending" one. This is the most consequential defect found anywhere on this page, since it directly misstates a core reported result rather than merely omitting context.
- **Falsity holds up well across the board.** Only two confirmed hallucinations exist on this entire page: Response B's transposed significance claim (the same defect driving its Accuracy failure) and Response C's "same specimens" overstatement (a real but low-materiality misrepresentation of the Western blot's role). Both are recognizable as consequences of the Accuracy findings, not independent fabrications — this page does not invent data.
- **Relevance is strong throughout**, with both purely-technical/tabular responses (B, C) scoring perfect 12/12s — a response with no prose narration has no room for the meta-commentary or scope-creep found in the two prose responses (A, D), both of which contain a recurring, specific type of digression: unverifiable cross-wiki/self-referential commentary ("a different pattern from most other sources in this wiki" in A; "introduces... as a biosample/biomarker category to this wiki" in D).

## Recommended fixes

1. **Response B, Findings table**: correct "Previa+PAS vs. control: Trended higher" (Bradford protein content) to "Significantly higher" — the source's Figure 1d caption confirms this comparison reached significance; the genuinely non-significant comparison is already correctly stated in the adjacent column (PAS vs. previa-without-PAS).
2. **Response A**: add "congenital fetal abnormalities" to the control exclusion-criteria list, or qualify the list as partial (e.g., "among other criteria").
3. **Response C**: clarify that the Western blot validation step used a representative subset (n=6 per group), distinct from the full n=35/35 cohort used for the quantitative Bradford and flow-cytometry comparisons.
4. **Responses A and D**: reconsider the self-referential "this wiki"/"this corpus" framing clauses — either remove them or move this kind of cross-page organizational commentary into a consistent, clearly-marked editorial note distinct from the source-grounded content.
5. **Across A, C, D**: consider adding a brief interpretive-context line drawing on the source's own Discussion (the "first-time" novelty claim, the explicit underpowering rationale, and the proposed biological mechanism) — this is the single highest-yield fix for Completeness across the page.

Final overall PASS/FAIL judgment across all category verdicts is a human call, not made here.
